MedPath

河北美图制药有限责任公司

Ownership
-
Established
1990-09-04
Employees
-
Market Cap
-
Website
meituzhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

51

NMPA:51

Drug Approvals

Carmustine

Product Name
卡莫司汀
Approval Number
国药准字H20063812
Approval Date
Apr 27, 2025
NMPA

Gentamycin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H13021433
Approval Date
Oct 27, 2020
NMPA

Adenosine Disodium Triphosphate Injection

Product Name
三磷酸腺苷二钠注射液
Approval Number
国药准字H13022455
Approval Date
Oct 27, 2020
NMPA

Ribavirin Injection

Product Name
利巴韦林注射液
Approval Number
国药准字H13021430
Approval Date
Oct 27, 2020
NMPA

Vitamin B6 Injection

Product Name
维生素B6注射液
Approval Number
国药准字H13021441
Approval Date
Oct 27, 2020
NMPA

Gentamycin Sulfate Injection

Product Name
硫酸庆大霉素注射液
Approval Number
国药准字H13021434
Approval Date
Oct 27, 2020
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H13021250
Approval Date
Oct 27, 2020
NMPA

Vitamin B12 Injection

Product Name
维生素B12注射液
Approval Number
国药准字H13021440
Approval Date
Oct 27, 2020
NMPA

Procaine Hydrochloride Injection

Product Name
盐酸普鲁卡因注射液
Approval Number
国药准字H13021834
Approval Date
Oct 27, 2020
NMPA

Vitamin C Injection

Product Name
维生素C注射液
Approval Number
国药准字H13021254
Approval Date
Oct 27, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.